关注
Elisabet I Nielsen
Elisabet I Nielsen
Department of Pharmacy
在 farmaci.uu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs
EI Nielsen, LE Friberg
Pharmacological reviews 65 (3), 1053-1090, 2013
3422013
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization
EI Nielsen, O Cars, LE Friberg
Antimicrobial agents and chemotherapy 55 (10), 4619-4630, 2011
2662011
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments
EI Nielsen, A Viberg, E Löwdin, O Cars, MO Karlsson, M Sandström
Antimicrobial agents and chemotherapy 51 (1), 128-136, 2007
2002007
From therapeutic drug monitoring to model‐informed precision dosing for antibiotics
SG Wicha, AG Märtson, EI Nielsen, BCP Koch, LE Friberg, JW Alffenaar, ...
Clinical Pharmacology & Therapeutics 109 (4), 928-941, 2021
1552021
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
T Tängdén, V Ramos Martín, TW Felton, EI Nielsen, S Marchand, ...
Intensive care medicine 43, 1021-1032, 2017
1282017
Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants
AF Mohamed, EI Nielsen, O Cars, LE Friberg
Antimicrobial agents and chemotherapy 56 (1), 179-188, 2012
1042012
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study
EI Nielsen, M Sandström, PH Honoré, U Ewald, LE Friberg
Clinical pharmacokinetics 48, 253-263, 2009
962009
Levodopa‐entacapone‐carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
M Senek, EI Nielsen, D Nyholm
Movement Disorders 32 (2), 283-286, 2017
952017
A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates
RFW De Cock, K Allegaert, CMT Sherwin, EI Nielsen, M de Hoog, ...
Pharmaceutical research 31, 754-767, 2014
952014
Simulation-based evaluation of PK/PD indices for meropenem across patient groups and experimental designs
AN Kristoffersson, P David-Pierson, NJ Parrott, O Kuhlmann, T Lave, ...
Pharmaceutical research 33, 1115-1125, 2016
652016
Direct analysis of artemisinin in plasma and saliva using coupled-column high-performance liquid chromatography with a restricted-access material pre-column
T Gordi, E Nielsen, Z Yu, D Westerlund, M Ashton
Journal of Chromatography B: Biomedical Sciences and Applications 742 (1 …, 2000
622000
Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections
A Di Paolo, C Tascini, M Polillo, G Gemignani, EI Nielsen, G Bocci, ...
International journal of antimicrobial agents 42 (3), 250-255, 2013
612013
Semi-mechanistic pharmacokinetic–pharmacodynamic modelling of antibiotic drug combinations
MJE Brill, AN Kristoffersson, C Zhao, EI Nielsen, LE Friberg
Clinical Microbiology and Infection 24 (7), 697-706, 2018
602018
Handling interoccasion variability in model‐based dose individualization using therapeutic drug monitoring data
JA Abrantes, S Jönsson, MO Karlsson, EI Nielsen
British journal of clinical pharmacology 85 (6), 1326-1336, 2019
582019
Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants
E Germovsek, A Kent, T Metsvaht, I Lutsar, N Klein, MA Turner, ...
Antimicrobial agents and chemotherapy 60 (8), 4869-4877, 2016
542016
Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model
AF Mohamed, AN Kristoffersson, M Karvanen, EI Nielsen, O Cars, ...
Journal of Antimicrobial Chemotherapy 71 (5), 1279-1290, 2016
542016
A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants
DD Khan, P Lagerbäck, S Cao, U Lustig, EI Nielsen, O Cars, D Hughes, ...
Journal of Antimicrobial Chemotherapy 70 (11), 3051-3060, 2015
532015
A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection
MW Sadiq, EI Nielsen, D Khachman, JM Conil, B Georges, G Houin, ...
Journal of pharmacokinetics and pharmacodynamics 44, 69-79, 2017
482017
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors
J Brem, T Panduwawala, JU Hansen, J Hewitt, E Liepins, P Donets, ...
Nature Chemistry 14 (1), 15-24, 2022
462022
Predicting In Vitro Antibacterial Efficacy across Experimental Designs with a Semimechanistic Pharmacokinetic-Pharmacodynamic Model
EI Nielsen, O Cars, LE Friberg
Antimicrobial agents and chemotherapy 55 (4), 1571-1579, 2011
462011
系统目前无法执行此操作,请稍后再试。
文章 1–20